Advocate. Educate. Care.

Global training, research, and grassroots advocacy in psychedelic healthcare.

ENROLLING 2026

Psychedelic therapy training

Small cohorts, supervision, and a pathway to supervised experiential training. In-person and online.

banner-img-1

Upcoming training

Rich Tyo

Toronto

with Rich Tyo

Psilocybin • five days

May 25-29, 2026

Ingrid

Vancouver

with Dr. Ingrid Pacey

MDMA • SIX DAYS

May 25-30, 2026

Rich Tyo

Online

with Rich Tyo

Psilocybin • Wednesdays

July 8–Sept 9, 2026
6-9 PM ET

Approved for MAiD. Denied psilocybin therapy.

People facing end of life deserve access to every meaningful option, including psychedelics.

Who we are

Founded on Vancouver Island in 2019, TheraPsil supports clinicians, researchers, and patients worldwide, creating a trusted ecosystem for psychedelic healthcare.

home-img-2

Patient support

Psychedelic-assisted psychotherapy pairs psychedelic substances with professional guidance. We connect qualified individuals to trained providers and offer clear guidance about this emerging field.

home-img-7

Education & training

World-class psychedelic therapy training for healthcare professionals. Our programs help you master the skills to safely and effectively transform care for your patients.

home-img-10

What are psychedelics?

Psychedelics are transformative tools for healthcare, inducing therapeutic states that enable deep healing. Combined with psychotherapy, they can deliver results for those in need.

In the news

forbes-logo-2
cbc-3
macleans-
bloomberg-logo-2
globe-and-mail-logo-1

In the news

forbes-logo-2
cbc-3
macleans-
bloomberg-logo-2
globe-and-mail-logo-1

Legal advocacy & community

A 2023 poll showed that 80% of Canadians believe that psilocybin represents a reasonable medical choice. Since our inception, TheraPsil has been working on the ground level, advocating for psychedelic regulations in Canada.

Subscribe to our newsletter!

Be the first to hear about new trainings, legal updates, and community events. Join TheraPsil’s newsletter and stay connected to Canada’s psychedelic advocacy and training community.

Help expand compassionate access

Support TheraPsil’s work to improve access to psychedelic therapy for patients in Canada.

Support the campaign